Superbugs


  • FDA Approves DORIBAX™ for the Treatment of Complicated Intra-Abdominal and Complicated Urinary Tract Infections
    RARITAN, N.J. -- The U.S. Food and Drug Administration (FDA) has approved DORIBAXTM (doripenem for injection) as a new treatment for complicated intra-abdominal and complicated urinary tract infections, including pyelonephritis. DORIBAX has demonstrated activity against a ...More
    October 15, 2007 Posted in News
  • Infectious Diseases Experts Applaud Bill Against "Bad Bugs"
    ARLINGTON, Va. -- With extensively drug-resistant tuberculosis, life-threatening drug-resistant respiratory and skin infections, and other "bad bugs" routinely making headlines, infectious diseases physicians are applauding Rep. Jim Matheson (D-UT) and Rep. Michael Ferguson ...More
    October 1, 2007 Posted in News
  • Study Says Cranberries Provide Urinary Tract Protection for up to Two Years
    LAKEVILLE-MIDDLEBORO, Mass. -- According to the National Kidney Foundation, one in five women will develop a urinary tract infection (UTI) during her lifetime, and 20 percent of those will have UTIs on a recurrent basis. The good news is that cranberry research supports not ...More
    August 13, 2007 Posted in News
  • Effective Infection Prevention Programs Include Proactive Measures
    Abstract The U.S. healthcare system is burdened with 3.2 billion dollars of added cost each year to battle multi-drug-resistant organisms (MDROs). The two primary organisms are methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-resistant Enterococcus (VRE), ...More
    July 2, 2007 Posted in Articles
  • Do You Know Where Your Foley Is?
    During the fall of 2004, the Idaho infection control department at Saint Alphonsus Regional Medical Center (SARMC) in Boise, Idaho, began using a Web-based data-mining software system (MedMined). As a result of using MedMined, it was identified that SARMC’s Urine Nosocomial ...More
    July 2, 2007 Posted in Articles
  • TOC July 2007
    Getting to the Point of Sharps Safety Best Practices Facilities Embrace Sharps Safety Plans at Different Speeds and Success Rates By Michelle Beaver Safety Syringes: Is Your Institution Stuck in the Stone Age? By Barbara DeBaun, RN, MSN, CIC Catheters and Infection ...More
    July 2, 2007 Posted in Articles
  • IDSA Urges Congress to Support Hatch Amendment; Provisions Would Counter the Threat of Drug-Resistant Superbugs
    The Infectious Diseases Society of America (IDSA) is calling on members of Congress to support the "Antibiotic Safety and Innovation" amendment introduced by Sen. Orrin Hatch (R-UT) to the Food Drug Administration (FDA) Revitalization Act. Without innovative public policy, ...More
    May 1, 2007 Posted in News
  • Johns Hopkins Begins Aggressive Screening for Superbugs in Children
    Infection control and critical care experts at the Johns Hopkins Hospital have ordered testing for the two most common hospital superbugs for every child admitted to its pediatric intensive care unit. The more stringent admission screening methods for methicillin-resistant ...More
    April 17, 2007 Posted in News
  • Most-at-Risk Nursing Home Residents to be Tested for Superbugs
    A Johns Hopkins study of adult patients admitted to the Johns Hopkins Hospital showed that patients who resided in nursing homes or other kinds of long-term care facilities at any time within the last six months were far more likely than other adult patients to carry or be ...More
    April 17, 2007 Posted in News, PPE & Standard Precautions
  • The Fight Against UTIs Continues
    A healthy person who contracts a urinary tract infection (UTI) certainly has reason to be upset, but when that person is already sick and contracts a UTI from a catheter, the risk and outrage compounds. Data on the estimated cost of catheter-associated UTIs (CAUTIs) ...More
    April 2, 2007 Posted in Articles